Louise Henderson

Works at

Sources: reporter.nih.gov

Grants and prizes

  • National Cancer Institute

    R01, Lung Cancer Screening: Cumulative Risk and Multilevel Impact of False Positive Findings, R01CA285976, 2024–2029, 16 Jun 2026

  • National Cancer Institute

    R01, Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening, R01CA277756, 2023–2028, 16 Jun 2026

  • National Cancer Institute

    R01, Evaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and Settings, R01CA212014, 2017–2028, 1 Jun 2026

  • National Cancer Institute

    R21, Early detection of liver cancer among patients with cirrhosis and MASLD, R21CA313041, 2026–2028, 11 May 2026

  • National Cancer Institute

    UG1, Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB), UG1CA286949, 2024–2027, 12 Jan 2026

  • National Cancer Institute

    R01, Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening, R01CA251686, 2020–2025, 21 Jun 2023

Sources: reporter.nih.gov